Gastric cancer in a general hospital in Japan
β Scribed by Yoichi Ikeda; Yukiaki Haraguchi; Masaki Mori; Kiyoshi Kajiyama; Motoyuki Yamagata; Yosuke Adachi; Keizo Sugimachi
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 451 KB
- Volume
- 10
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
During 20 years from 1971 to 1990, 605 patients with gastric cancer were treated by gastric resection at a mediumβsize general hospital by one surgeon. The overall 5βyear survival rate was 61.9%. The 5βyear survival rates in the first 10 years (n = 261) and the second 10 years (n = 344) were 53.7% and 67.9%, respectively (P < 0.01). In the second 10 years there was a significant increase in the patients with early gastric cancer (P < 0.01). Meanwhile, operative procedure or R2 or R3 lymph node dissection did not show any improvement of the 5βyear survival rates. These results indicate that the prognosis for gastric cancer was relatively good at a general hospital which does not specialize in cancer research, and that much of the improvement in the prognosis could be attributed to the increase in the incidence of patients with early gastric cancer. Β© 1994 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Although standard radical gastrectomy for gastric cancer, including lymph node dissection of compartments I and II, has been commonly utilized in Japan, new trends in gastric cancer surgery recently have been developed. In the treatment of early gastric cancer, endoscopic and limited su
## Abstract Twenty years' experience of thyroid cancer in a district general hospital has been reviewed. Its incidence, prognosis and natural history have been studied. Particular attention has been focused on the relationship of malignant to benign goitre. The relevance of this to the treatment of
## Abstract The macroscopical and histological features of 4,428 cases of gastric cancer resected surgically between 1953 and 1974 were studied. Of these cases, 81.9% were in an advanced stage and 18.1% in an early stage. The following changes were observed. (1) In the group of advanced cancers, a